Selective use of intraoperative sentinel lymph node pathological evaluation in breast cancer

American Journal of Surgery

Volumn 196, Issue 6, 2008, Pages 851-856

  Gawlick, Ute ^a   Mone, Mary C ^a   Hansen, Heidi J ^a   Connors, Rafe C ^a   Nelson, Edward W ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Intraoperative pathological analysis; Sentinel lymph node

Indexed keywords

ISOSULFAN BLUE; TECHNETIUM SULFUR COLLOID TC 99M;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CYTODIAGNOSIS; CANCER STAGING; CYTOLOGY; FALSE NEGATIVE RESULT; FEMALE; FROZEN SECTION; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAOPERATIVE PERIOD; LOW RISK PATIENT; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MASTECTOMY; PARTIAL MASTECTOMY; PATHOLOGIST; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE; SURGICAL PATIENT;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; INTRAOPERATIVE PERIOD; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY;

EID: 57449114518     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2008.07.027     Document Type: Article

References (15)

1. Krag D.N., Anderson S.J., Julian T.B., et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8 (2007) 881-888 [CrossRef] [PubMed]
2. Ozmen V., and Cabioglu N. Sentinel lymph node biopsy for breast cancer: current controversies. Breast J 12 suppl 2 (2006) S134-S142 [CrossRef] [PubMed]
3. Veronesi U., Paganelli G., Viale G., et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349 (2003) 546-553 [CrossRef] [PubMed]
4. Alkhatib W., Connor C., and Fang F. Solitary positive sentinel lymph node accompanied by negative sentinel lymph node(s) is predictive of a negative completion axillary lymph node dissection. Am J Surg 194 (2007) 856-859 [CrossRef] [PubMed]
5. Benson J.R. Querci della Rovere G. Management of the axilla in women with breast cancer. Breast 16 (2007) 130-136 [CrossRef] [PubMed]
6. Park J., Fey J.V., Naik A.M., et al. A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram. Ann Surg 245 (2007) 462-468 [CrossRef] [PubMed]
7. Van Zee K.J., Manasseh D.M., Bevilacqua J.L., et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10 (2003) 1140-1151 [CrossRef] [PubMed]
8. Domenech A., Benitez A., Bajen M.T., et al. Patients with breast cancer and negative sentinel lymph node biopsy without additional axillary lymph node dissection: a follow-up study of up to 5 years. Oncology 72 (2007) 27-32 [CrossRef] [PubMed]
9. Bergkvist L., de Boniface J., Jonsson P.E., et al. Axillary recurrence rate after negative sentinel node biopsy in breast cancer: three-year follow-up of the Swedish multicenter Cohort Study. Ann Surg 247 (2008) 150-156 [PubMed]
10. Chagpar A.B., Carlson D.J., Laidley A.L., et al. Factors influencing the number of sentinel lymph nodes identified in patients with breast cancer. Am J Surg 194 (2007) 860-865 [CrossRef] [PubMed]
11. Chagpar A.B., Scoggins C.R., Martin II R.C., et al. Are 3 sentinel nodes sufficient?. Arch Surg 142 (2007) 456-460 [CrossRef] [PubMed]
12. Brogi E., Torres-Matundan E., Tan L.K., et al. The results of frozen section, touch preparation, and cytological smear are comparable for intraoperative examination of sentinel lymph nodes: a study in 133 breast cancer patients. Ann Surg Oncol 12 (2005) 173-180 [CrossRef] [PubMed]
13. Chan S.W., LaVigne K.A., Port E.R., et al. Does the benefit of sentinel node frozen section vary between patients with invasive duct, invasive lobular, and favorable histologic subtypes of breast cancer?. Ann Surg 247 (2008) 143-149 [PubMed]
14. Bevilacqua J.L., Kattan M.W., Fey J.V., et al. Doctor, what are my chances of having a positive sentinel node?. A validated nomogram for risk estimation. J Clin Oncol 25 (2007) 3670-3679 [CrossRef] [PubMed]
15. Hwang R.F., Gonzalez-Angulo A.M., Yi M., et al. Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection. Cancer 110 (2007) 723-730 [CrossRef] [PubMed]